ABVC BioPharma, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 98.6% | -3,290.1% | -3,608.5% |
| FY2022 | 70.5% | -1,558.5% | -1,693.5% |
| FY2023 | -98.1% | -4,439.2% | -5,109.3% |
| FY2024 | 99.9% | -923.3% | -962.1% |
| FY2025 | — | -2,416.0% | -2,671.8% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 98.6% | -3,290.1% | -3,608.5% |
| FY2022 | 70.5% | -1,558.5% | -1,693.5% |
| FY2023 | -98.1% | -4,439.2% | -5,109.3% |
| FY2024 | 99.9% | -923.3% | -962.1% |
| FY2025 | — | -2,416.0% | -2,671.8% |